showed a trendp = 0.07
II–IV), expression of miR-146a was higher in patients with severe GvHD (grade II–IV) compared to patients with no/mild aGvHD (grade 0–I) ( p = 0.003), while expression of miR-155 showed a trend to higher expression in patients with severe aGvHD (stage II–IV) ( p = 0.07).